Correlation Between Haleon Plc and Supernus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Haleon Plc and Supernus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haleon Plc and Supernus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Haleon plc and Supernus Pharmaceuticals, you can compare the effects of market volatilities on Haleon Plc and Supernus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haleon Plc with a short position of Supernus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haleon Plc and Supernus Pharmaceuticals.

Diversification Opportunities for Haleon Plc and Supernus Pharmaceuticals

-0.56

Correlation Coefficient

Haleon Plc  Supernus Pharmaceuticals

Excellent diversification

The 3 months correlation between Haleon and Supernus is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Haleon plc and Supernus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supernus Pharmaceuticals and Haleon Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haleon plc are associated (or correlated) with Supernus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supernus Pharmaceuticals has no effect on the direction of Haleon Plc i.e., Haleon Plc and Supernus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Haleon Plc and Supernus Pharmaceuticals

Considering the 90-day investment horizon Haleon plc is expected to generate 0.5 times more return on investment than Supernus Pharmaceuticals. However, Haleon plc is 2.0 times less risky than Supernus Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Supernus Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  967.00  in Haleon plc on December 1, 2024 and sell it today you would earn a total of  51.00  from holding Haleon plc or generate 5.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Haleon plc  vs.  Supernus Pharmaceuticals

Haleon plc

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Haleon plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy essential indicators, Haleon Plc is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Supernus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Supernus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Haleon Plc and Supernus Pharmaceuticals

The main advantage of trading using opposite Haleon Plc and Supernus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haleon Plc position performs unexpectedly, Supernus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supernus Pharmaceuticals will offset losses from the drop in Supernus Pharmaceuticals' long position.

The idea behind Haleon plc and Supernus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.